




























dPrognostic Effect of Long-Axis Left Ventricular Dysfunction and
B-Type Natriuretic Peptide Levels in Asymptomatic Aortic Stenosis
Patrizio Lancellotti, MD, PhDa,*, Marie Moonen, MDa, Julien Magne, PhDa, Kim O’Connor, MDa,
Bernard Cosyns, MDb, Emilio Attena, MDa, Erwan Donal, MDc, and Luc Pierard, MD, PhDa
In aortic stenosis (AS), the increased afterload results in progressive structural and func-
tional changes that precede the development of symptoms. We hypothesized that the
detection of abnormalities in left ventricular long-axis function could identify patients with
asymptomatic AS at increased risk of events. We prospectively examined the outcome of
126 patients with asymptomatic AS who underwent a comprehensive echocardiographic
examination, including tissue Doppler imaging. B-type natriuretic peptide (BNP) was
measured in all patients. During a median follow-up period of 20.3  17.8 months, 6
patients died, 8 developed symptoms but did not undergo surgery, and 48 underwent aortic
valve replacement. On multivariate Cox regression analysis, the parameters associated with
the predefined outcome were gender (p  0.048), left atrial area index (p  0.011), systolic
annular velocity (p  0.016), E/Ea ratio (p  0.024), late diastolic annular velocity (p 
0.023), and BNP (p  0.012). Using receiver operating characteristics curve analysis, a left
atrial area index of>12.4 cm2/m2, systolic annular velocity of<4.5 cm/s, E/Ea ratio>13.8,
late diastolic annular velocity of<9 cm/s, and BNP of>61 pg/ml were identified as the best
cutoff values to predict events. In conclusion, in asymptomatic AS, tissue Doppler imaging
and BNP measurements provide prognostic information beyond that from clinical and
conventional echocardiographic parameters. © 2010 Elsevier Inc. All rights reserved.



























cAortic valve stenosis (AS) is the most common valvular
isease and has become the most common cardiovascular
isease, after coronary artery disease and hypertension, in
eveloped countries.1 AS is characterized by a long asymp-
omatic phase, lasting several decades, during which out-
ow obstruction progressively develops.2 Aortic valve re-
lacement is the sole effective therapy for symptomatic
atients. In contrast, the management of asymptomatic AS
emains controversial.3,4 In these patients, the chronically
ncreased afterload results in progressive left ventricular
LV) myocardial hypertrophy and interstitial fibrosis, dia-
tolic dysfunction, elevated left atrial pressures, dilation of
he left atrium, and, eventually, intrinsic myocardial dys-
unction.5 These structural and functional changes precede
ymptom development, predict changes in clinical status,
nd trigger B-type natriuretic peptide (BNP) release.6,7 In
S, the BNP level correlates with the valve area, diastolic
unction, functional status, and symptomatic deterioration
nd might improve risk stratification.8–11 Tissue Doppler
easurement of mitral annular velocities is a sensitive
ethod for the detection of early abnormalities in LV long-
xis function and improves the assessment of LV diastolic
unction.12 In asymptomatic AS, the incremental prognostic
alue of tissue Doppler imaging and BNP measurement
aDepartment of Cardiology, University Hospital Sart Tilman, Liège,
elgium; bCHIREC, Braine l’Alleud, Belgium; and cCHU de Ponchaillou,
ennes, France. Manuscript received July 2, 2009; revised manuscript
eceived and accepted September 8, 2009.
*Corresponding author: Tel: (32) 4-366-7194; fax: (32) 4-366-
195.
vE-mail address: plancellotti@chu.ulg.ac.be (P. Lancellotti).
002-9149/10/$ – see front matter © 2010 Elsevier Inc. All rights reserved.
oi:10.1016/j.amjcard.2009.09.043ompared with validated parameters has never been inves-
igated. The present study was undertaken to prospectively
ssess the comparative usefulness in predicting the clinical
utcomes of long-axis function and BNP level in a series of
atients with asymptomatic severe AS.
ethods
Asymptomatic patients with severe AS were prospec-
ively screened from our echocardiographic laboratory for
nclusion in the present study. All the patients met the
ollowing criteria: (1) moderate to severe AS, as defined by
n aortic valve area of 1.2 cm2; (2) no symptoms accord-
ng to a careful history taken by the referring physician; (3)
ormal LV ejection fraction (55%), as calculated by 2-di-
ensional echocardiography; (4) no more than mild asso-
iated cardiac valve lesions; (5) sinus rhythm; and (6) serum
reatinine 16 mg/L. A total of 126 patients met these
riteria. The relevant institutional review boards approved
he protocol, and all patients gave written informed consent.
A comprehensive Doppler echocardiographic study, in-
luding M-mode, 2-dimensional echocardiography, color
oppler, and pulsed-wave and continuous-wave Doppler
easurements was performed, in all patients using a VIVID
ultrasound machine (General Electric Healthcare, Little
halfont, United Kingdom). The images were stored on a
edicated workstation for off-line analysis. For each mea-
urement, 2 cardiac cycles were averaged. Continuous-
ave Doppler was used to measure the aortic transvalvular
aximal velocities; the peak and mean gradients were cal-
ulated using the simplified Bernoulli equation. The aortic



























































384 The American Journal of Cardiology (www.AJConline.org)he LV end-diastolic and end-systolic volumes and ejection
raction were measured using the bi-apical Simpson disk
ethod.14 The left atrial area was obtained by planimetry in
igure 1. Receiver operating characteristics curves of predictors of out-
ome. Aa  late diastolic annular velocity; LAAI  left atrial area index;




(n  64, 51
ge (years) 68  10
omen 16 (25%)
ypertension 29 (43%)
iabetes mellitus 12 (19%)
ypercholesterolemia 28 (44%)
ystolic arterial pressure (mm Hg) 144  18
-type natriuretic peptide (pg/ml) 39.9  27
erum creatinine (mg/l) 8.2  1.8
bnormal response to exercise 6 (9)
ortic valve area (cm2) 0.86  0.1
eak aortic velocity (m/s) 4.03  0.5
ortic peak pressure gradient (mm Hg) 69.7  19
ortic mean pressure gradient (mm Hg) 42.4  13
eft ventricular mass (g) 174  86
eft ventricular end-diastolic volume (ml) 92.8  26
eft ventricular end-systolic volume (ml) 32.2  14
eft ventricular ejection fraction (%) 65.8  7.4
eft atrial area index (cm2/m2) 10.3  2.1
itral early diastolic filling wave (cm/s) 77  24
itral late diastolic filling wave (cm/s) 87  29
itral early/late diastolic filling ratio 0.92  0.3
itral early diastolic filling wave deceleration time (ms) 219 78
eak systolic velocity (cm/s) 5.2  0.9
eak early diastolic annular velocity (cm/s) 9.95  1.7
eak late diastolic annular velocity (cm/s) 8.7  2
arly diastolic filling/annular velocity (average annuli) 10 3.3
* Parameters selected on the multivariate Cox regression analysis.end-systolic frames of the apical 4-chamber view. Color oissue Doppler imaging was performed in the apical views
2 and 4 chamber) to assess longitudinal myocardial func-
ion (frame rate 115/s).14 Off-line peak systolic velocities
btained at the level of the septal, lateral, inferior, and
nterior mitral annulus were measured separately and then
veraged. An effort was made to align each of the LV walls
s near to 0° as possible to the long-axis motion. For
iastolic function, the peak velocities of early (E) and late
A) diastolic filling, E/A ratio, deceleration time, and iso-
olumic relaxation time were derived from Doppler record-
ngs of LV inflow. Using pulsed-wave tissue Doppler, the
eak velocities during early (Ea) and late (Aa) diastole
Events
(n  62, 49%)
Univariate Multivariate
p Value p Value Hazard Ratio (95% CI)
67  12 0.51 — —
35 (56%) 0.00024 0.048* 0.53 (0.28–0.99)*
32 (52%) 0.51 — —
12 (19%) 0.97 — —
26 (42%) 0.34 — —
141  19 0.55 — —
166  237 0.0001 0.012* 1.001 (1–1.003)*
8.7  1.7 0.14 — —
26 (42) 0.007 0.88 0.95 (0.49–1.8)
0.79  0.16 0.05 0.80 1.49 (0.06–34)
4.35  0.58 0.0013 0.58 1.31 (0.5–3.4)
77  21 0.01 — —
46.7  13. 0.046 0.32 1.02 (0.9–1.06)
169  67 0.85 — —
96.9  30.3 0.94 — —
32.5  13 0.91 — —
67.4  7.5 0.52 — —
14.8  3.4 0.0001 0.011* 1.06 (1.01–1.11)*
83  26 0.12 — —
89  28 0.29 — —
0.99  0.48 0.53 — —
237  97 0.34 — —
3.6  1.6 0.0001 0.016* 0.73 (0.57–0.94)*
7.9  1.8 0.025 0.91 1.01 (0.84–1.2)
7.6  2.1 0.0001 0.023* 0.81 (0.67–0.97)*
13.5  6.6 0.009 0.024* 0.94 (0.88–0.99)*
able 2
rea under curve, sensitivity, specificity, and optimal cutoff values of
ignificant variables for predicting outcome





eft atrial area index
(cm2/m2)
12.4 0.90 83.9% 90.6%
eak systolic velocity
(cm/s)
4.5 0.87 88.7% 82.8%
eak Aa velocity (cm/s) 9 0.81 80.6% 75%
arly diastolic filling/
annular velocity
13.8 0.67 42% 88%
-type natriuretic
peptide (pg/ml)




















































385Valvular Heart Disease/Prognosis of Long-Axis Dysfunction in ASere measured separately and then averaged. The E/Ea ratio
as then calculated.
Venous blood samples for BNP measurement were
rawn before echocardiography, after 10 minutes of supine
est. Chilled ethylenediaminetetraacetic acid tubes were
entrifuged immediately at 4,000 rpm (4°C) for 15 minutes.
eparated plasma samples were processed by immunofluo-
escence assay (Biosite, Beckman Coulter, San Diego, Cal-
fornia). The inter- and intra-assay variation was 5% and
%, respectively. The assay detection limit was 1 pg/ml.
Symptom-limited graded bicycle exercise tests were per-
ormed at inclusion for all patients. After an initial workload
f 25 W maintained for 2 minutes, the load was increased by
teps of 25 W every 2 minutes. The exercise test was
nterrupted when the age-related maximum heart rate was
eached or if symptoms, hypotension, or significant ventric-
lar arrhythmias developed. The test was considered abnor-
al if the patient presented with 1 of the following cri-
eria: (1) angina, (2) evidence of dyspnea, (3) dizziness, (4)
yncope or near-syncope, (5) and increase in systolic blood
ressure during exercise of 20 mm Hg or a decrease in
igure 2. The four figures represent the Kaplan-Meier event-free survival
ultivariate model to predict the outcome in asymptomatic patients with A
ystolic velocity; (D) Aa: late diastolic annular velocity.lood pressure, and (6) ventricular tachycardia or 4 pre- aature ventricular complexes in a row. Because the present
tudy was conducted before the official recommendations of
007, the results of the exercise test, even when abnormal,
id not affect patient treatment.
Follow-up information was obtained from interviews
ith the patients, their relatives, or their physicians every 6
o 12 months, according to the guidelines. Particular care
as taken to obtain information regarding the development
f symptoms, eventual aortic valve replacement, and death.
he clinical management was determined independently by
he patient’s personal physician using all information avail-
ble. The combined end point included the onset of symp-
oms (angina, dyspnea, syncope, heart failure), cardiac-re-
ated death, and the need for aortic valve replacement.
Continuous variables are expressed as the mean  SD,
nless otherwise specified. Group comparisons for categor-
cal variables were obtained using the chi-square test and for
ontinuous variables with 1-way analysis of variance. Anal-
sis was performed by censoring follow-up data at cardiac
urgery, if eventually performed. To detect independent
redictors of events, a multivariate Cox proportional haz-
according the following categorical variables which were selected in the
BNP: B-Type Natriuretic Peptide; (B) LA: left atrial area; (C) PSv: peakcurves































































386 The American Journal of Cardiology (www.AJConline.org)ho remained asymptomatic during follow-up and those
ho experienced an event (STATISTICA, version 7, Stat-
oft, France). All clinically relevant variables with p 0.10
ere included in the multivariate model. p Values 0.05
ere considered significant. Receiver operating character-
stic curve analysis was performed to determine the cutoff
alues that best distinguished the issue (area under the
urve). Survival curves were established using the Kaplan-
eier method, and statistical significance was determined
sing the log-rank test.
esults
The mean patient age was 67  10 years (range 41 to
4). From the patient history and echocardiographic analy-
is findings, the suspected origin of AS was calcification of
trileaflet (n  104), bicuspid (n  15), rheumatic disease
commissural fusion and calcification most prominent along
he edges of the cusps on echocardiography; n  5), and
ndetermined (n  2). The aortic valve area range was 0.38
o 1.2 cm2 (mean 0.82  0.15), and the peak aortic pressure
radient was 77  21 mm Hg. The mean aortic pressure
radient was 26 to 86 mm Hg (mean 45  14). The mean
V ejection fraction was 67 7% (range 55% to 84%), and
he mean peak annular systolic velocity was 4.5  1.5 cm/s
range 0.84 to 9). The mean BNP level was 102  178
g/ml (range 5 to 1,500). At inclusion, the exercise test
ndings were abnormal (dyspnea in 20, decrease or increase
n systolic blood pressure during exercise of20 mm Hg in
, and combined parameters in 6) in 32 patients (25%).
uring a median follow-up period of 20.3  18.7 months
interquartile range 9 to 22), the predefined end point oc-
urred in 62 patients. Of the 62 patients, 6 patients died
igure 3. Example of patient with severe AS and impaired long-axis functi
raction; MPG  mean transaortic pressure gradient; PSv  peak systolicrom cardiovascular causes: 3 suddenly and 3 from progres- tive heart failure. Aortic valve replacement was required for
he development of symptoms in 34 patients, new-onset
trial fibrillation in 1, newly positive exercise test findings
n 7, and equivocal symptoms in 6. Finally, 8 patients
eveloped symptoms but refused to undergo surgery.
The clinical and echocardiographic characteristics of the
atients who remained asymptomatic or experienced an
vent are listed in Table 1. No clinical data, except female
ender, allowed the distinction between the 2 groups. Pa-
ients who experienced an end point had a smaller aortic
alve area, lower tissue Doppler annular systolic and dia-
tolic velocities, and a greater E/Ea ratio, left atrial area, and
NP level. The response to exercise was more often abnor-
al in these patients. On multivariate Cox regression anal-
sis, the parameters independently associated with the pre-
efined composite outcome were gender, left atrial area
ndex, systolic annular velocity, E/Ea, late diastolic annular
elocity (Aa), and BNP level (Figure 1, Table 2). Figure 2
hows the survival curves for categorical variables, and
igure 3 shows an example of a patient with impaired
ong-axis function. In the subgroup of patients with a
ormal response to exercise, except for the E/Ea, the
ther parameters remained independently associated with
he outcome.
iscussion
The decision to perform surgery on asymptomatic pa-
ients with AS remains controversial.3,4 The immediate risks
f surgery are often weighed against the later risk of events
ithout intervention.15 Therefore, reliable risk stratification
s clinically important.16–18 In the present prospective study,
e report, for the first time, the added prognostic value of
 late diastolic annular velocity; AVA  aortic valve area; EF  ejection



















































































387Valvular Heart Disease/Prognosis of Long-Axis Dysfunction in AShe classical clinical and echocardiographic parameters in a
rospective series of patients with asymptomatic moderate
o severe AS. Patients, particularly females, with impaired
ong-axis function and increased BNP levels were at in-
reased risk of untoward events.
In AS, the chronically increased afterload results in pro-
ressive LV remodeling and myocardial hypertrophy.19 Al-
hough the increase in LV wall thickness is a compensatory
echanism that reduces systolic wall stress, it can result in
mpaired LV relaxation, reduced LV compliance, and in-
reased metabolic demands. The ability of the LV to ade-
uately fill under normal pressures is thus altered, and the
V diastolic pressure increases. As a result, LV filling
ecomes more dependent on the atrial contribution. In the
dvanced stage of the disease, the chronic increase in LV
lling pressure is accompanied by progressive left atrial
nlargement and dysfunction.20 Elevated LV diastolic pres-
ure also limits the coronary perfusion pressure with a
eduction of the subendocardial coronary flow reserve,
hich leads to myocardial ischemia even in the absence of
ignificant coronary artery disease.21 Despite appropriate
ypertrophy and accumulation of collagen in the subendo-
ardial region, the LV ejection fraction can be classically
aintained within the normal range for years.22 This reflects
he preserved contribution of radial thickening to LV func-
ion. In contrast, the LV longitudinal function will be im-
aired because of subendocardial dysfunction. Initially, sub-
ndocardial dysfunction might normalize after aortic valve
urgery.23
In the present study, except for female gender, neither
he clinical findings (i.e., age, risk factors, exercise test) nor
tandard echocardiographic parameters (i.e., severity of ste-
osis, LV mass, LV volume, LV ejection fraction, extent of
alve calcification) emerged as independent predictors of
utcome. However, the prognostic effect of these factors
as probably weakened by the inclusion of almost specif-
cally elderly patients (in which the positive predictive value
f exercise testing is limited) and the analysis of more
owerful predictors of outcome such as BNP level and
issue Doppler parameters.24,25 In these patients, the in-
reased release of BNP from the ventricles could reflect the
ubstantial gender differences in the LV adaptive responses
o AS.26 BNP has been shown to be associated with the
rognosis in several cardiovascular diseases such as AS.7–11
n heart failure, the predictive value of BNP seems to be
reater in women than in men.27 Our results have confirmed
he strong prognostic value of BNP in a cohort of patients
ith asymptomatic AS.
The current guidelines consider surgery as reasonable in
atients with asymptomatic severe AS and reduced LV
jection fraction (50%).3,4 However, the LV ejection frac-
ion is often normal in these patients. In contrast to this
rude estimate of the LV systolic function, tissue Doppler
maging is superior for detecting subtle changes in myocar-
ial function.12 Measurements of myocardial systolic annu-
ar velocities reflect longitudinal motion owing to the lon-
itudinally directed fibers, which are mainly located in the
ubendocardium and subepicardium. When the velocities
re averaged from the 4 regions of the annulus, they reflect
he global long-axis function. In patients with asymptomatic
S, impaired subendocardial function has been shown to be
1ssociated with impaired exercise tolerance and changes in
ymptomatic status during short-term follow-up.6,22 Our
esults have extended these preliminary data by showing
hat the decrease in long-axis function can identify a subset
f patients with moderate to severe asymptomatic AS at
reater risk of developing cardiac events.
In the present study, we found that the left atrial area, late
iastolic annular velocity (Aa), and E/Ea ratio were strong
ndependent predictors of outcome. The left atrial size re-
ects the chronicity of diastolic burden.28 A value of 12.4
m2/m2 provided high predictive accuracy for cardiac
vents. The late diastolic annular velocity reliably quantifies
he left atrial contribution to LV filling. In these patients, the
eft atrial booster pump function has a crucial role in coun-
eracting the increased LV end-diastolic pressure and the
elayed LV untwisting to maintain optimal cardiac output.29
reduction in left atrial function might thus favor clinical
eterioration. In our population, a late diastolic annular
elocity of 9 cm/s was associated with an excess risk of
eath, symptoms, or surgery. An increased E/Ea ratio, an
stimate of LV pre-A pressure, has been shown to be an
mportant marker of adverse events in patients with pre-
erved LV function.12 In the present study, we found that an
/Ea ratio 13.8 identified a subset of patients with AS at
reater risk of future events.
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